Frailty, defined as an age-related state of increased vulnerability to acute stressors, is a
major challenge in the care of older people with haematological malignancies. Growing …

Background and aims: Inappropriate medication prescription is highly prevalent in older
adults and is associated with adverse health outcomes. The aim of this study was to …

Background: Polypharmacy and potentially inappropriate medications (PIMs) are common
among older adults with blood cancers, but their association with frailty and how to manage …

Multiple myeloma (MM) is associated with the highest symptom burden and lowest health-
related quality of life (HRQoL) among patients with hematologic malignancies. HRQoL in …

Aims Diabetes mellitus type 2 (DMT2) is a major chronic condition that also common in older
people, and associated with an increased risk of falling. This study aimed to determine the …

Polypharmacy is common in older adults with cancer, but there is little evidence evaluating
the impact of polypharmacy and other medication hazards on allogeneic hematopoietic cell …

Background: Survival in multiple myeloma (MM) has improved in the past years with the
introduction of immunomodulators and proteasome inhibitors. However …

Background Fractures have serious health consequences in older adults. While some
medications are individually associated with increased risk of falls and fractures, it is not …

Introduction: The present study has compiled the prevalence of polypharmacy worldwide
and assessed the prevalence of polypharmacy in different populations, including community …

Background: Hematological malignancies (HMs) are a heterogeneous group of cancers
representing a significant cause of morbidity and mortality. The chronification of HMs and the …